• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠V1a和V2精氨酸加压素受体的分子克隆与表达

Molecular cloning and expression of rat V1a and V2 arginine vasopressin receptors.

作者信息

Morel A, Lolait S J, Brownstein M J

机构信息

Département de Biologie Cellulaire et Moléculaire, Centre d'Etudes de Saclay, Gif sur Yvette, France.

出版信息

Regul Pept. 1993 Apr 29;45(1-2):53-9. doi: 10.1016/0167-0115(93)90182-8.

DOI:10.1016/0167-0115(93)90182-8
PMID:8511367
Abstract

Vasopressin, one of the first characterized neuropeptides, has a wide spectrum of biological action, acting on distinct tissues. Indeed, it is involved in water retention, glucose metabolism, blood pressure and its implication in the CNS has also been described. This diversity of effects on mammalian tissues is mediated by distinct G protein-coupled receptors, acting via distinct second messenger pathways. This receptor family has been subtyped by pharmacological studies, as V1a receptor whose action is mediated by intracellular calcium mobilization, and V2 receptor which is linked to adenylyl cyclase. Since so many essential functions were ensured by vasopressin, molecular characterization of its receptors became soon a great challenge. This prompted us to isolate the cDNA of AVP V1a receptor as the first member of this family, by expression cloning. Intracellular calcium mobilization was therefore assayed after rat liver mRNA injection into Xenopus oocytes. A single clone, encoding a functional AVP receptor corresponding to the V1a subtype was finally characterized as a G protein-coupled receptor. Furthermore, we used homology cloning strategy in order to clone the AVP V2 subtype from a rat kidney cDNA library. A putative receptor clone was finally characterized as the rat V2 receptor cDNA by binding and cAMP increase experiments, on transfected cells.

摘要

血管加压素是最早被鉴定的神经肽之一,具有广泛的生物学作用,作用于不同的组织。实际上,它参与水潴留、葡萄糖代谢、血压调节,其在中枢神经系统中的作用也已被描述。血管加压素对哺乳动物组织的这种多样作用是由不同的G蛋白偶联受体介导的,通过不同的第二信使途径发挥作用。通过药理学研究,这个受体家族已被分为不同亚型,如作用由细胞内钙动员介导的V1a受体,以及与腺苷酸环化酶相关的V2受体。由于血管加压素确保了如此多的重要功能,其受体的分子特征很快就成为了一个巨大的挑战。这促使我们通过表达克隆分离出AVP V1a受体的cDNA,作为该家族的第一个成员。因此,在将大鼠肝脏mRNA注射到非洲爪蟾卵母细胞后,检测细胞内钙动员情况。最终鉴定出一个编码与V1a亚型相对应的功能性AVP受体的单一克隆,它是一种G蛋白偶联受体。此外,我们使用同源克隆策略,从大鼠肾脏cDNA文库中克隆AVP V2亚型。通过对转染细胞进行结合和cAMP增加实验,最终将一个推定的受体克隆鉴定为大鼠V2受体cDNA。

相似文献

1
Molecular cloning and expression of rat V1a and V2 arginine vasopressin receptors.大鼠V1a和V2精氨酸加压素受体的分子克隆与表达
Regul Pept. 1993 Apr 29;45(1-2):53-9. doi: 10.1016/0167-0115(93)90182-8.
2
Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor.编码人血管升压素V1a受体的cDNA的分子克隆、测序及功能表达
J Biol Chem. 1994 Feb 4;269(5):3304-10.
3
Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor.编码人V1b血管加压素受体的cDNA的分子克隆与功能表达
J Biol Chem. 1994 Oct 28;269(43):27088-92.
4
Extrapituitary expression of the rat V1b vasopressin receptor gene.大鼠V1b血管加压素受体基因的垂体外表达。
Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6783-7. doi: 10.1073/pnas.92.15.6783.
5
Molecular cloning and expression of a rat V1a arginine vasopressin receptor.大鼠V1a精氨酸加压素受体的分子克隆与表达
Nature. 1992 Apr 9;356(6369):523-6. doi: 10.1038/356523a0.
6
Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist.强效非肽类人血管加压素V1A和V2受体拮抗剂YM087的药理学特性
Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):63-9. doi: 10.1007/pl00005139.
7
Potentiation of receptor-mediated cAMP production: role in the cross-talk between vasopressin V1a and V2 receptor transduction pathways.受体介导的环磷酸腺苷(cAMP)生成的增强作用:在血管加压素V1a和V2受体转导途径之间的相互作用中的作用。
Biochem J. 1998 Mar 1;330 ( Pt 2)(Pt 2):1023-8. doi: 10.1042/bj3301023.
8
Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus.血管加压素V2受体的克隆与特性分析及其与肾性尿崩症的可能联系。
Nature. 1992 May 28;357(6376):336-9. doi: 10.1038/357336a0.
9
Structure of the rat V1a vasopressin receptor gene and characterization of its promoter region and complete cDNA sequence of the 3'-end.大鼠V1a血管加压素受体基因的结构及其启动子区域的特征和3'端完整cDNA序列
J Biol Chem. 1995 Aug 25;270(34):20042-50. doi: 10.1074/jbc.270.34.20042.
10
Evidence for dual signaling pathways for V2 vasopressin receptor in rat inner medullary collecting duct.大鼠髓质内集合管中V2血管加压素受体双重信号通路的证据。
Am J Physiol. 1996 Apr;270(4 Pt 2):F623-33. doi: 10.1152/ajprenal.1996.270.4.F623.

引用本文的文献

1
Synthesis and Application of Novel Arginine Vasopressin Receptor 1A (AVPR1A) Antagonists.新型精氨酸加压素受体1A(AVPR1A)拮抗剂的合成与应用
ACS Med Chem Lett. 2025 May 29;16(6):963-964. doi: 10.1021/acsmedchemlett.5c00285. eCollection 2025 Jun 12.
2
Interplay of Angiotensin Peptides, Vasopressin, and Insulin in the Heart: Experimental and Clinical Evidence of Altered Interactions in Obesity and Diabetes Mellitus.血管紧张肽、血管加压素和胰岛素在心脏中的相互作用:肥胖和糖尿病中相互作用改变的实验和临床证据。
Int J Mol Sci. 2024 Jan 21;25(2):1310. doi: 10.3390/ijms25021310.
3
The Heart as a Target of Vasopressin and Other Cardiovascular Peptides in Health and Cardiovascular Diseases.
心作为血管加压素和其他心血管肽在健康和心血管疾病中的靶标。
Int J Mol Sci. 2022 Nov 20;23(22):14414. doi: 10.3390/ijms232214414.
4
Arginine vasopressin: Direct and indirect action on metabolism.精氨酸血管加压素:对代谢的直接和间接作用。
Peptides. 2021 Aug;142:170555. doi: 10.1016/j.peptides.2021.170555. Epub 2021 Apr 24.
5
Regulation of renal Na-(K)-Cl cotransporters by vasopressin.血管加压素对肾脏钠 -(钾)- 氯协同转运蛋白的调节作用。
Pflugers Arch. 2017 Aug;469(7-8):889-897. doi: 10.1007/s00424-017-2002-2. Epub 2017 Jun 2.
6
The Relationship between Renal Dysfunction and Abnormalities of the Immune System in Patients with Decompensated Cirrhosis.失代偿期肝硬化患者肾功能不全与免疫系统异常的关系
ISRN Gastroenterol. 2012;2012:123826. doi: 10.5402/2012/123826. Epub 2012 Dec 26.
7
Molecular Architecture of G Protein-Coupled Receptors.G蛋白偶联受体的分子结构
Drug Dev Res. 1996 Jan 1;37(1):1-38. doi: 10.1002/(SICI)1098-2299(199601)37:1<1::AID-DDR1>3.0.CO;2-S.
8
Upregulation of vasopressin V1A receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment.环孢素A处理后血管平滑肌细胞中血管加压素V1A受体mRNA和蛋白的上调。
Br J Pharmacol. 2001 Feb;132(4):909-17. doi: 10.1038/sj.bjp.0703878.